Review paper
Efficacy and safety of abatacept in interstitial lung disease of rheumatoid arthritis: A systematic literature review
Abstract
Interstitial lung disease (ILD) is a serious complication that represents the second leading cause of death in patients with rheumatoid arthritis (RA). Treatment of RA-ILD remains controversial. The absence of randomized clinical trials and specific ACR or EULAR therapeutic guidelines makes it difficult to establish solid therapeutic recommendations on this issue. In this scenario, real-world data is especially valuable.To review the literature...
Paper Details
Title
Efficacy and safety of abatacept in interstitial lung disease of rheumatoid arthritis: A systematic literature review
Published Date
Jun 1, 2021
Journal
Volume
20
Issue
6
Pages
102830 - 102830
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History